TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25647773

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation with noise-cancelling headphones and eye masks for 3 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 12
Study: 23978192

Group type: EXPERIMENTAL
Intervention: Chronic Bronchitis (CB+)
Number of subjects: 234

Group type: COMPARATOR
Intervention: No Chronic Bronchitis (CB-)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Severe Chronic Bronchitis (SCB+)
Number of subjects: 234

Group type: COMPARATOR
Intervention: No Severe Chronic Bronchitis (SCB-)
Number of subjects: 234
Study: 21106930

Group type: COMPARATOR
Intervention: Yellow-flesh potatoes (YP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Purple-flesh potatoes (PP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: White-flesh potatoes (WP)
Number of subjects: 36
Study: 19994615

Group type: EXPERIMENTAL
Intervention: Supreme Laryngeal Mask Airway (SLMA)
Number of subjects: 85

Group type: COMPARATOR
Intervention: I-gel Supraglottic Airway (IGSA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Supreme Laryngeal Mask Airway (SLMA) and I-gel Supraglottic Airway (IGSA)
Number of subjects: 85
Study: 17885010

Group type: EXPERIMENTAL
Intervention: Soy germ pasta (80-g serving/d)
Number of subjects: 62
Study: 15166388

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg daily for 2 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 12
Study: 11599834

Group type: EXPERIMENTAL
Intervention: ADCON-L gel
Number of subjects: 398

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 398
Study: 9479681

Group type: EXPERIMENTAL
Intervention: Clinician-Administered Dissociative States Scale (CADSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other psychiatric disorders and healthy subjects
Number of subjects: 0
Study: 8305411

Group type: EXPERIMENTAL
Intervention: High-unsaturated fat diet
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: High-saturated fat diet
Number of subjects: 5

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 5
Study: 2494567

Group type: EXPERIMENTAL
Intervention: Low-protein diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-protein diet
Number of subjects: 10
Study: 30646198

Group type: EXPERIMENTAL
Intervention: Regular exercise during pregnancy (16-week supervised exercise program including aerobic and resistance training, 60-minute sessions, 3 times per week)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Regular exercise during pregnancy
Number of subjects: 639

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 639
Study: 29202548

Group type: EXPERIMENTAL
Intervention: Smoker Diabetics (n=45)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nonsmoker Diabetics (n=45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Healthy Controls (n=10)
Number of subjects: 90
Study: 25879513

Group type: EXPERIMENTAL
Intervention: Sucrose-sweetened beverage consumption three times per day for 2 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Aspartame-sweetened beverage consumption three times per day for 2 weeks
Number of subjects: 19
Study: 23672733

Group type: EXPERIMENTAL
Intervention: SILE program (structured individual‐based lifestyle education) delivered by registered dietitians over 4 sessions during 6 months
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: SILE program
Number of subjects: 193
Study: 22166044

Group type: EXPERIMENTAL
Intervention: modular multi‐modal exercise intervention group
Number of subjects: 90

Group type: COMPARATOR
Intervention: usual medical care group
Number of subjects: 90
Study: 19502032

Group type: EXPERIMENTAL
Intervention: Pentax‐AWS airway scope
Number of subjects: 520

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 520
Study: 17034278

Group type: EXPERIMENTAL
Intervention: Homeopathic combination therapy
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 15064026

Group type: EXPERIMENTAL
Intervention: Insecticide spraying
Number of subjects: 7080

Group type: EXPERIMENTAL
Intervention: Provision of pit latrines
Number of subjects: 7080

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 7080
Study: 11349393

Group type: EXPERIMENTAL
Intervention: Naltrexone treatment
Number of subjects: 92
Study: 9608970

Group type: EXPERIMENTAL
Intervention: granisetron (40 micrograms.kg‐1, n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: droperidol (50 micrograms.kg‐1, n = 40)
Number of subjects: 80
Study: 8157197

Group type: EXPERIMENTAL
Intervention: Laser excision
Number of subjects: 80

Group type: COMPARATOR
Intervention: Loop diathermy (LLETZ)
Number of subjects: 80
Study: 3280615

Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Flurazepam 30 mg
Number of subjects: 8
Study: 30325913

Group type: EXPERIMENTAL
Intervention: Endurance Training Group (ETG)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG)
Number of subjects: 16
Study: 26656669

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Both LSG and LRYGB
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 42

Group type: COMPARATOR
Intervention: Preoperative indirect calorimetry and DEXA results
Number of subjects: 42
Study: 25603738

Group type: COMPARATOR
Intervention: Microwave Diathermy Group (heated by microwave before stretching)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treadmill Group (warm-up walking before stretching)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 30-Second Group (30 s of stretching)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 10-Minute Group (stretching for 10 min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control Group (no specific intervention)
Number of subjects: 50
Study: 23088252

Group type: EXPERIMENTAL
Intervention: Thulium laser vaporesection of the prostate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 80
Study: 20849542

Group type: EXPERIMENTAL
Intervention: ALA‐IPL PDT
Number of subjects: 26

Group type: COMPARATOR
Intervention: IPL only
Number of subjects: 26
Study: 19060423

Group type: EXPERIMENTAL
Intervention: Food frequency and quantity method
Number of subjects: 76
Study: 16566838

Group type: EXPERIMENTAL
Intervention: Adherence to World Health Organisation guidelines for body mass index, waist circumference, and waist/hip ratio
Number of subjects: 1621

Group type: EXPERIMENTAL
Intervention: Short-term weight gain (women only)
Number of subjects: 1621
Study: 14647086

Group type: EXPERIMENTAL
Intervention: 667 mg encapsulated sucralose daily for 13 weeks
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (cellulose) capsules daily for 13 weeks
Number of subjects: 128
Study: 10588126

Group type: EXPERIMENTAL
Intervention: SPIR/FLAIR sequence
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced T1-weighted SPIR images
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: SPIR/FLAIR technique
Number of subjects: 34
Study: 8949786

Group type: EXPERIMENTAL
Intervention: Lomefloxacin 400 mg once a day for three days
Number of subjects: 595

Group type: COMPARATOR
Intervention: Pefloxacin 800 mg once a day for three days
Number of subjects: 595
Study: 2224374

Group type: EXPERIMENTAL
Intervention: Buspirone (5 mg t.d.s.)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 23
Study: 363216

Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with pyloroplasty
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with antrectomy
Number of subjects: 36
Study: 30081698

Group type: EXPERIMENTAL
Intervention: Topical tazarotene 0.1% after fractional CO2 laser treatment
Number of subjects: 102

Group type: COMPARATOR
Intervention: Topical tioconazole 28% after fractional CO2 laser treatment
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: KOH test and culture results after treatment in Group A
Number of subjects: 102

Group type: COMPARATOR
Intervention: KOH test and culture results after treatment in Group B
Number of subjects: 102
Study: 27987182

Group type: EXPERIMENTAL
Intervention: Supervised modified step aerobics training (twice weekly, 1 hour per session) over a period of 6 months
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study: 25879367

Group type: EXPERIMENTAL
Intervention: TENS stimulation during radiotherapy (Group S1B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TENS stimulation during radiotherapy (Group S1A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TENS stimulation after radiotherapy (Group S2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 40
Study: 24727345

Group type: EXPERIMENTAL
Intervention: 2-week group-based multicomponent treatment course
Number of subjects: 192

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 192
Study: 22410382

Group type: EXPERIMENTAL
Intervention: Dexamethasone (5 mg daily for 4 days)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 19588641

Group type: EXPERIMENTAL
Intervention: Tretinoin microsphere gel pump 0.04% (TMG PUMP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tazarotene cream 0.05% (TAZ)
Number of subjects: 0
Study: 17616006

Group type: EXPERIMENTAL
Intervention: 200 mg grape seed extract (calculated as proanthocyanidin)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 400 mg grape seed extract (calculated as proanthocyanidin)
Number of subjects: 61
Study: 14693623

Group type: EXPERIMENTAL
Intervention: K‐K9 acupressure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 100
Study: 12217604

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2a (40KD)
Number of subjects: 814
Study: 9700132

Group type: EXPERIMENTAL
Intervention: 0.2 ppm O3 for 4 hours on 4 consecutive days
Number of subjects: 15

Group type: COMPARATOR
Intervention: 0.2 ppm O3 for 4 hours on a single day
Number of subjects: 15
Study: 7858359

Group type: EXPERIMENTAL
Intervention: Spiritual healing
Number of subjects: 24

Group type: COMPARATOR
Intervention: No active treatment
Number of subjects: 24
Study: 3675134

Group type: EXPERIMENTAL
Intervention: mCPP (0.5 mg/kg, orally)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: mCPP
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls (N=20)
Number of subjects: 12
Study: 30143478

Group type: EXPERIMENTAL
Intervention: Church-based weight loss intervention with SMS text messages (10 sessions, 6 months)
Number of subjects: 97

Group type: COMPARATOR
Intervention: SMS text messages related to health conditions (delayed intervention)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Number of SMS text messages sent
Number of subjects: 97
Study: 27426424

Group type: EXPERIMENTAL
Intervention: Behavioral intervention to reduce alcohol use
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Self-reported alcohol use
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Semistructured interviews
Number of subjects: 127
Study: 25397623

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Systematic inguinofemoral lymph node dissection (ILND)
Number of subjects: 128
Study: 23901678

Group type: EXPERIMENTAL
Intervention: Cinitapride 1mg thrice daily 15 minutes before meals for 4 weeks
Number of subjects: 121
Study: 20363044

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 155

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 155
Study: 18440347

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 4162

Group type: COMPARATOR
Intervention: Pravastatin 40 mg daily
Number of subjects: 4162
Study: 19968382

Group type: EXPERIMENTAL
Intervention: Brief experiential psychotherapy
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Beginning therapy alliance (after Session 1)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Clients' beginning therapy process
Number of subjects: 74
Study: 15885904

Group type: EXPERIMENTAL
Intervention: Group A (familiarized with procedures)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Group B (received only verbal instructions)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 11472271

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin analogues (general)
Number of subjects: 0
Study: 9455271

Group type: EXPERIMENTAL
Intervention: Polyurethane foam dressing
Number of subjects: 61

Group type: COMPARATOR
Intervention: Hydrocolloid dressing
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both dressings
Number of subjects: 61
Study: 8188798

Group type: EXPERIMENTAL
Intervention: Preventive intervention in first grade and middle school
Number of subjects: 1000
Study: 3115841

Group type: EXPERIMENTAL
Intervention: L-lysine monohydrochloride (1,000 mg per dose, 3 times a day for 6 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31916789

Group type: EXPERIMENTAL
Intervention: Incredible Years Teacher Classroom Management (IY TCM)
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Wait-list comparison group (Control)
Number of subjects: 1817
Study: 30710652

Group type: EXPERIMENTAL
Intervention: 8% arginine and calcium carbonate in-office prophylaxis paste and respective toothpaste
Number of subjects: 273

Group type: COMPARATOR
Intervention: Fluoride-free prophylaxis paste and sodium monofluorophosphate toothpaste
Number of subjects: 273
Study: 30146649

Group type: EXPERIMENTAL
Intervention: At-home bleaching
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 43
Study: 27020947

Group type: EXPERIMENTAL
Intervention: Community-based cluster randomised trial (CRT)
Number of subjects: 20
Study: 25039273

Group type: COMPARATOR
Intervention: LY3000328 (up to 300 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: LY3000328
Number of subjects: 21
Study: 22503610

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker + calcium channel blocker
Number of subjects: 1164

Group type: COMPARATOR
Intervention: High-dose angiotensin II receptor blocker (40 mg/d olmesartan)
Number of subjects: 1164
Study: 19459794

Group type: EXPERIMENTAL
Intervention: MMF(CC) and reduced-level calcineurin inhibitor (MMF(CC)/CNI(RL))
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: MMF(CC) and standard-level CNI (MMF(CC)/CNI(SL))
Number of subjects: 720

Group type: COMPARATOR
Intervention: fixed-dose MMF and CNI(SL) (MMF(FD)/CNI(SL))
Number of subjects: 720
Study: 17514528

Group type: EXPERIMENTAL
Intervention: Customized aspheric algorithm (32 patients, group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional algorithm (26 patients, group B)
Number of subjects: 58
Study: 15479685

Group type: EXPERIMENTAL
Intervention: Patient oriented self management approach
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Patient oriented self management training
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 700
Study: 11476427

Group type: EXPERIMENTAL
Intervention: Peak oxygen uptake (VO2peak) measured in boys and girls
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Allometric regression standards with sexes separated
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Subcutaneous fat increase in girls during puberty
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: VO2peak expressed as ml kg(‐1) min(‐1)
Number of subjects: 195
Study: 9631839

Group type: EXPERIMENTAL
Intervention: Dietary protein restriction
Number of subjects: 1919
Study: 7932683

Group type: EXPERIMENTAL
Intervention: Biofeedback, imagery, and breathing training for 5 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Treatment subjects
Number of subjects: 84
Study: 2962876

Group type: EXPERIMENTAL
Intervention: Human atrial natriuretic peptide (hANP: 50 micrograms h‐1 for 6 h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Norepinephrine (NE: 50 ng kg‐1 min‐1)
Number of subjects: 6
Study: 29883885

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous paracetamol every 4 h for 72 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% sodium chloride every 4 h for 72 h
Number of subjects: 0
Study: 27841759

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4,400 IU/day)
Number of subjects: 881

Group type: COMPARATOR
Intervention: Control group (400 IU/day)
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Sufficient vitamin D status (25OHD ≥30 ng/ml)
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Differential expression of vitamin D‐associated genes
Number of subjects: 881
Study: 25134364

Group type: EXPERIMENTAL
Intervention: Glass Carbomer sealant (group B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resin-based sealant (group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 23528262

Group type: EXPERIMENTAL
Intervention: ATRA
Number of subjects: 379

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: 1 year ATRA
Number of subjects: 379

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 379
Study: 20585969

Group type: EXPERIMENTAL
Intervention: Single-dose fosfomycin trometamol (FMT) 3 g
Number of subjects: 260

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg twice a day for 5 days
Number of subjects: 260
Study: 19008768

Group type: EXPERIMENTAL
Intervention: Radiosurgery for brain AVMs
Number of subjects: 30
Study: 16323126

Group type: EXPERIMENTAL
Intervention: Antimalarial treatment (specific regimens not detailed)
Number of subjects: 1965

Group type: EXPERIMENTAL
Intervention: New infections (molecular genotyping)
Number of subjects: 1965

Group type: EXPERIMENTAL
Intervention: Recrudescences (molecular genotyping)
Number of subjects: 1965
Study: 15456051

Group type: EXPERIMENTAL
Intervention: Passive transverse forces (PTF) applied on the deformed body, 4 to 6 treatments lasting 20 minutes each, combined with intensive rehabilitation.
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group with intensive inpatient rehabilitation alone.
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: PTF treatment without additional braces (n=52).
Number of subjects: 126

Group type: COMPARATOR
Intervention: Inpatient rehabilitation alone (control group without brace).
Number of subjects: 126
Study: 15321153

Group type: EXPERIMENTAL
Intervention: 10 degrees head-up position
Number of subjects: 100

Group type: COMPARATOR
Intervention: Horizontal position
Number of subjects: 100
Study: 7742155

Group type: EXPERIMENTAL
Intervention: Fasting for 24 hours after a standard supper
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-fasting (eating a standard supper, snacks, breakfast, and lunch)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fasting for 24 hours
Number of subjects: 37
Study: 2038216

Group type: EXPERIMENTAL
Intervention: Prophylactic sclerosis
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (no prophylactic sclerosis)
Number of subjects: 46
Study: 7197959

Group type: EXPERIMENTAL
Intervention: Urapidil (2 times 25 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Phentolamine (2 times 5 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Phentolamine
Number of subjects: 20
Study: 28834330

Group type: EXPERIMENTAL
Intervention: Classical music during the procedure
Number of subjects: 62

Group type: COMPARATOR
Intervention: No music during the procedure
Number of subjects: 62
Study: 28682461

Group type: EXPERIMENTAL
Intervention: Presentation of 5-year stroke risk graphic
Number of subjects: 968

Group type: COMPARATOR
Intervention: Presentation of 1-year stroke risk graphic
Number of subjects: 968

Group type: COMPARATOR
Intervention: Physician prescribing to themselves
Number of subjects: 968
Study: 26408012

Group type: EXPERIMENTAL
Intervention: High-dose intensity-modulated radiation therapy (IMRT) combined with androgen deprivation therapy (ADT) for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 23631604

Group type: EXPERIMENTAL
Intervention: CGM pre‐CSII
Number of subjects: 16

Group type: COMPARATOR
Intervention: CGM post‐CSII
Number of subjects: 16
Study: 21542927

Group type: COMPARATOR
Intervention: No sedation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sedation
Number of subjects: 103
Study: 19587583

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 17174640

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose
Number of subjects: 68

Group type: COMPARATOR
Intervention: Clopidogrel 300 mg loading dose
Number of subjects: 68
Study: 15204628

Group type: EXPERIMENTAL
Intervention: Counterstereotype information
Number of subjects: 149

Group type: COMPARATOR
Intervention: Stereotype information
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study: 16206677

Group type: EXPERIMENTAL
Intervention: Oxymatrine (intravenous or intra-muscular injection and oral capsule)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Tiopronin (control group)
Number of subjects: 303
Study: 9872196

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 microg by metered‐dose inhaler)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 7884169

Group type: EXPERIMENTAL
Intervention: Triple therapy (tripotassium dicitrato bismuthate 125 mg q.i.d., tetracycline hydrochloride 500 mg q.i.d., metronidazole 500 mg t.i.d.)
Number of subjects: 245